Charles Schwab’s Tecogen Inc TGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,000
Closed -$59.3K 3534
2025
Q4
$59.3K Hold
12,000
﹤0.01% 3418
2025
Q3
$106K Buy
+12,000
New +$96.2K ﹤0.01% 3389
2020
Q2
Sell
-11,344
Closed -$11K 3368
2020
Q1
$11K Hold
11,344
﹤0.01% 3215
2019
Q4
$25K Hold
11,344
﹤0.01% 3155
2019
Q3
$27K Hold
11,344
﹤0.01% 3148
2019
Q2
$43K Hold
11,344
﹤0.01% 3162
2019
Q1
$46K Buy
+11,344
New +$43.6K ﹤0.01% 3149

Other funds holding TGEN

Charles Schwab's TGEN Position: Q1 2026 in Review

Charles Schwab sold out of Tecogen Inc (TGEN) in Q1 2026, closing a stake of 12,000 shares — an estimated $59.3K sold.

Charles Schwab first reported a position in TGEN in Q1 2019 and held it in 7 quarters. The position peaked at $106K in Q3 2025. 62 funds tracked by Wall St. Rank hold TGEN as of Q1 2026.

  • Charles Schwab reported no remaining Tecogen Inc position as of Q1 2026 after selling out during the quarter.
  • Charles Schwab sold 12,000 Tecogen Inc shares in Q1 2026, an estimated $59.3K.
  • Charles Schwab first reported a position in Tecogen Inc in Q1 2019 and held it in 7 quarters.
  • Charles Schwab's Tecogen Inc position peaked at $106K in Q3 2025.
  • 62 funds tracked by Wall St. Rank held Tecogen Inc as of Q1 2026.

Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.